Amneal Return On Assets from 2010 to 2024

AMRX Stock  USD 8.32  0.09  1.07%   
Amneal Pharmaceuticals, Return On Assets yearly trend continues to be fairly stable with very little volatility. Return On Assets are likely to outpace its year average in 2024. Return On Assets is a profitability ratio that indicates the percentage of profit Amneal Pharmaceuticals, Class earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
(0.02)
Current Value
(0.02)
Quarterly Volatility
0.11329785
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 119.8 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.42, Dividend Yield of 0.096 or PTB Ratio of 56.75. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Amneal Pharmaceuticals, Class over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Amneal Pharmaceuticals,'s Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Slightly volatile
   Return On Assets   
       Timeline  

Amneal Return On Assets Regression Statistics

Arithmetic Mean0.07
Coefficient Of Variation169.61
Mean Deviation0.10
Median0.12
Standard Deviation0.11
Sample Variance0.01
Range0.3348
R-Value(0.79)
Mean Square Error0.01
R-Squared0.63
Significance0.0004
Slope(0.02)
Total Sum of Squares0.18

Amneal Return On Assets History

2024 -0.023
2023 -0.0242
2022 -0.0671
2021 0.00512
2020 0.0171
2019 -0.16
2018 -0.039

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Return On Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Assets(0.02)(0.02)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.